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Objectives. To determine the long-term effects of
unfiltered coffee consumption on the activity levels of
cholesteryl ester transfer protein (CETP), phospholipid
transfer protein (PLTP) and lecithin:cholesterol
acyltransferase (LCAT) and to assess a possible role
of CETP activity levels in the rise in serum LDL
cholesterol.
Subjects and design. Forty-six healthy normolipi-
daemic subjects consumed 0.9 L of either French-
press or filtered coffee for 24 weeks. Fasting blood
samples were obtained after 0, 2, 12 and 24 weeks of
intervention and after and 12 weeks of follow-up.
Main outcome measures. Serum activity levels of
CETP, PLTP and LCAT.
Results. Relative to baseline, French-press coffee
significantly increased average CETP activity by 12%
after 2 weeks, by 18% after 12 weeks, and by 9% after
24 weeks. PLTP activity was significantly increased
by 10% after 12 and 24 weeks. LCAT activity was
significantly decreased by 6% after 12 weeks and by
7% after 24 weeks. The increase in CETP clearly
preceded the increase in LDL cholesterol, but not the
increase in total triglycerides. However, consumption
of French-press coffee caused a persistent rise in CETP
activity, whereas the rise in serum triglycerides was
transient.
Conclusions. Consumption of cafestol and kahweol
cause a long-term increase in CETP as well as PLTP
activity; the increase in CETP activity may contribute
to the rise in LDL cholesterol.
Keywords: cafestol, French-press coffee, kahweol,
normolipidaemic subjects, serum lipid transfer pro-
teins.
Introduction
Long-term consumption of unfiltered coffee potently
raises serum low-density lipoprotein (LDL) choles-
terol in humans [1]. The lipid-soluble diterpenes
cafestol and kahweol ± present in coffee beans [2] ±
are responsible for this effect [3]. Unfiltered coffee
brews like French-press coffee, Scandinavian boiled
coffee and Turkish coffee contain 3±6 mg of each
diterpene per cup [2]. These diterpenes are the most
potent cholesterol-raising substances from the diet
that are known. Therefore, the action of cafestol and
kahweol offers an interesting model to study the
effect of dietary substances on cholesterol metabo-
lism in humans.
The mechanism of action of cafestol and kahweol
is poorly understood. In vitro studies show contra-
dictory results in various cell lines. Cafestol de-
creased LDL receptor activity in human fibroblasts
[4], in HepG2-cells [5] and in primary rat hepato-
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cytes [6]. However, in CaCo2-cells, cafestol en-
hanced LDL cholesterol uptake and degradation
[7]. We have previously found that, in humans,
short-term consumption of diterpenes is associated
with increased serum activity levels of the lipid
transfer proteins cholesteryl ester transfer protein
(CETP) and phospholipid transfer protein (PLTP) and
with decreased activity levels of lecithin:cholesterol
acyltransferase (LCAT) [8]. CETP catalyses the
transfer of cholesteryl esters ± synthesized by LCAT
± from HDL to the apolipoprotein B-containing
lipoproteins LDL and VLDL [9]. PLTP can affect the
net mass transfer of phospholipids between lipopro-
teins [10] and it also converts small-sized HDL
(HDL3) into both larger (HDL2-sized) and smaller
(pre-b-migrating) HDL particles [11±13]. Both CETP
and PLTP appear to play a major role in determining
the concentration and size of HDL particles in
plasma [10, 14]. In our earlier short-term study
[8], it remained unclear whether the elevated serum
CETP and PLTP activity levels in subjects consuming
diterpenes were a cause or a consequence of the
raised LDL cholesterol concentrations.
In the present study, we studied the long-term
effects of French-press coffee consumption on serum
lipid transfer proteins and LCAT. In addition, we
compared the initial changes occurring in CETP
activity levels with the initial changes in LDL and
HDL cholesterol and total triglycerides during
French-press coffee consumption. Filtered coffee
was used as a control. We reasoned that an increase
in CETP activity prior to an increase in LDL
cholesterol could indicate a role of this protein in
the mechanism of cafestol and kahweol to raise LDL
cholesterol concentrations in humans.
Subjects and methods
Subjects
Approval for the experiments was obtained from the
Human Ethics Committee of the Division of Human
Nutrition & Epidemiology, Wageningen University.
Forty-six healthy normolipidaemic subjects gave
their written informed consent and participated in
the study. The baseline characteristics of the subjects
are indicated in Table 1. These subjects had a mean
age of 30 years (range 19±69) and a body mass
index (BMI) of 23 6 1 (mean 6 SEM) kg m22.
Sixteen of these subjects were smokers. Alcohol
consumption was limited to less than 3 beverages
day21 per subject.
Design
During a run-in period of 4 weeks, subjects
consumed 0.9 L day21 of filtered coffee. Subse-
quently, they were stratified by age then randomly
allocated to consume 0.9 L day21 of either filtered
coffee (n = 24 subjects; 12 male and 12 female) or
French-press coffee (n = 22 subjects; 11 male and
11 female) for 24 weeks. Subjects brewed their
coffee at home. Filtered coffee was prepared by
scooping 33 g of finely ground coffee into a paper
filter and pouring 1.1 L of boiling water onto the
grounds. Boiled coffee was prepared by scooping
39 g of coarse grounds into a cafetieÁre (Kaffee
Primo, BMF, Germany) and pouring 1.2 L of boiling
water onto the grounds. Subjects stirred the brew for
10 s, allowed it to stand for 2±5 min, pushed down
the plunger to separate the grounds from the brew,
and then decanted the brew. This amount of French-
press coffee provided about 38 mg day21 of cafestol
and 33 mg day21 of kahweol. Filtered coffee pro-
vided less than 1 mg day21 of either diterpene.
Both coffee brews contained similar amounts of
caffeine.
Blood sampling and assays
Fasting venous blood samples were taken after 0, 2,
12 and 24 weeks of intervention and after 12 weeks
of follow-up. Serum was obtained by centrifugation
and stored at ±808C. Total serum triglycerides, LDL
cholesterol and HDL cholesterol were assayed as
described [1]. Serum CETP activity levels were
assayed in duplicate after removal of endogenous
VLDL + LDL [15] using excess exogenous substrates.
The isotope assay measures the transfer of [1-14C-
oleate]cholesteryl ester from labelled LDL to an
excess of unlabelled pooled normal HDL, whilst
LCAT is inhibited with dithiobis-2-nitrobenzoic acid
[16]. CETP activity was calculated as the bidirec-
tional transfer between labelled LDL and HDL. The
CETP activity levels obtained by this method
correlate well with CETP mass [17]. Serum PLTP
activity levels were assayed in duplicate in a
phospholipid vesicles-HDL system, as previously
described [15]. In short, small serum samples of
0.5±1.0 mL were incubated with [3H]phosphatidyl-
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choline-labelled liposomes and an excess of pooled
normal HDL, followed by precipitation of the
liposomes with a mixture of NaCl, MgCl2 and
heparin (final concentrations of 230 mmol L21,
32 mmol L21 and 200 U mL21, respectively). The
measured PLTP activity is not influenced by the
phospholipid transfer promoting properties of CETP
[15]. Serum LCAT activity levels were measured in
duplicate, using excess exogenous substrate contain-
ing [3H]cholesterol as described [18]. The measured
activity is indicative for the serum LCAT concentra-
tion [19]. Serum CETP, PLTP and LCAT activity
levels were related to human pool serum and
expressed in arbitrary units (AU, which corresponds
to the percentages of the activities present in the
serum pool). All subjects were analysed using one
batch of substrates. The within-assay coefficients of
variation of CETP, PLTP and LCAT were 2.7, 3.5
and 4.5%, respectively.
Statistics
Responses were calculated by subtracting baseline
values from values obtained during treatment. All
variables were normally distributed. Differences in
responses between the French-press and filtered-
coffee group were tested against zero with unpaired
t-tests.
Results
Consumption of French-press coffee significantly
increased CETP activity by 12% after 2 weeks, by
18% after 12 weeks and by 9% after 24 weeks.
PLTP activity was significantly increased by 10%
after 12 and 24 weeks. LCAT activity was signifi-
cantly decreased by 6% after 12 weeks and by 7%
after 24 weeks. Both CETP and PLTP activity
dropped just below baseline after consumption of
French-press coffee had ceased. LCAT returned to
baseline after cessation of treatment (Fig. 1).
After 2 weeks of French-press coffee consumption,
CETP had already reached 68% of the maximal
increase that was reached after 12 weeks of inter-
vention. The increase in LDL cholesterol only
became significant after 12 weeks. At 2 weeks,
LDL cholesterol had only reached 18% of the
maximal increase that was reached after 12 weeks
of intervention. As reported previously [1], triglycer-
ides, and thus presumably VLDL, had already
peaked at the first measuring point, after which
levels slowly returned to baseline. No significant
changes were detected in HDL cholesterol (Fig. 1).
Discussion
Long-term consumption of French-press coffee
increased CETP and PLTP activity and decreased
LCAT activity in a group of healthy normolipidaemic
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Table 1 Baseline characteristics of the subjects consuming filtered coffee (n = 24) or French-press coffee (n = 22) for 6 months. Values are
means ( SEM) unless stated otherwise
Filtered
coffee
French-press
coffee
Gender (n, male/female) 12/12 11/11
Age (years) 29  2 30  2
Body mass index (kg m22) 22  1 23  1
Smoking (n, yes/no)a 10/14 6/16
Daily amount of alcoholic drinksa 1.0  0.1 0.7  0.2
Serum lipid levels
Total cholesterol (mmol L21) 5.0  0.2 4.9  0.2
LDL cholesterol (mmol L21)b 3.0  0.2 3.0  0.2
Triglycerides (mmol L21) 1.1  0.1 1.1  0.1
Serum lipid transfer proteins
Cholesteryl ester transfer protein (%) 105.0  5.4 107.7  6.2
Phospholipid transfer protein (%) 95.5  2.9 91.6  3.4
Lecithin:cholesterol acyltransferase (%) 95.5  2.2 95.7  2.6
aSelf-reported consumption.
bCalculated according to Friedewald et al. [36].
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subjects. We also found that consumption of French-
press coffee increased CETP activity before it
increased LDL cholesterol. During consumption of
French-press coffee, CETP activity levels had already
reached 68% of their maximum increase at the first
measurement point, 2 weeks after subjects had
started to drink unfiltered coffee rich in cafestol. At
that point in time, LDL levels had reached only 18%
of their maximum increase (Fig. 1).
The present findings extend our earlier short-term
data obtained with purified coffee diterpenes [8]. In
our previous experiments, which lacked frequent
sampling at early time periods, it remained unclear
whether elevated activity levels of CETP and PLTP
due to cafestol or kahweol consumption were a
cause or a consequence of elevated serum LDL
cholesterol levels [8]. Earlier human studies on the
effects of a high-fat, high-cholesterol diet on serum
CETP also do not provide clear evidence for a causal
relationship, e.g. in favour of a mechanism with
increased serum CETP activity levels causing in-
creased serum LDL cholesterol levels [20±22]. Data
from animal models are not conclusive either. Some
studies in transgenic mice suggest that increased
CETP levels may be secondary to increased LDL
cholesterol levels. When mice carrying the human
CETP gene were cross-bred with hyperlipidaemic
mice which had a deficiency in either apolipoprotein
E or the LDL receptor, plasma CETP levels were
increased to values higher than those found in
normolipidaemic mice carrying the human CETP
gene [23]. However, other studies showed that
expression of the monkey CETP gene in mice raised
plasma levels of LDL, a class of lipoproteins which is
virtually absent in wild-type mice [24]. Rats injected
intravenously with purified human CETP also
showed increased LDL and apolipoprotein B con-
centrations [25]. In the present study, the increase
in CETP activity levels preceded the increase in LDL
cholesterol, although triglycerides, and thus pre-
sumably VLDL, rose rapidly on cafestol. One could
argue that the rise in CETP may itself have been
caused by the rise in VLDL. However, serum
triglycerides levels returned to baseline after 2 weeks
of French-press coffee consumption, whereas the
CETP activity remained significantly increased
(Fig. 1). This finding might therefore support a role
for CETP in the effect of cafestol on LDL levels in
humans.
PLTP activity also increased upon long-term
French-press coffee consumption. This is in agree-
ment with data from our previous study in which
subjects consumed coffee diterpenes [8]. PLTP and
CETP belong to the same lipid transfer protein/
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Fig. 1 Mean changes from baseline
values in serum activity levels of
CETP, PLTP and LCAT and in
serum concentrations of LDL and
HDL cholesterol and serum
triglycerides in 22 subjects drinking
0.9 L day21 of French-press coffee
for 24 weeks. For each time point,
mean changes from baseline in 24
subjects drinking filtered coffee
were subtracted from those in the
subjects drinking French-press
coffee. The error bars represent the
standard error of the mean
difference. Statistical differences
between the two intervention
groups (P , 0.05) are indicated by
an asterisk (*).
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lipopolysaccharide binding protein (LTP/LBP) gene
family [26]. Both proteins are upregulated by
cholesterol feeding in animal studies [27, 28],
suggesting that their genes contain cholesterol-
responsive elements [9]. A parallel increase in both
lipid transfer proteins might therefore be expected.
Serum LCAT activity levels decreased slightly after
consumption of French-press coffee. A comparable
decrease was observed earlier after consumption of
purified coffee diterpenes [8]. Since LCAT is solely
synthesized in the liver [19], an impairment of liver
function, as evident from increased activities of
serum transaminases after French-press coffee con-
sumption [1], may explain the decrease in serum
LCAT levels. Because LCAT primarily functions in
the formation of HDL cholesteryl esters, a lower
LCAT activity may result in decreased HDL choles-
terol levels, especially when CETP activity is
increased. Indeed, cafestol and kahweol were found
to lower serum HDL cholesterol in one previous
study [3], although not in other studies [29, 30],
nor in the present study. However, HDL cholesteryl
esters can have two different metabolic fates: CETP-
mediated transfer to triglyceride-rich lipoproteins
[9], or direct delivery to (liver) cells via the
scavenger receptor class B type I (SR-BI) [31]. The
mechanisms involved in the control of SR-BI are still
unclear. The promoter region of the human SR-BI
gene contains consensus-DNA binding sequences for
several transcription factors, including sterol regu-
latory element binding proteins (SREBP). Transcrip-
tional regulation by SREBP or other factors is the
most likely means of regulation of SR-BI expression
by dietary cholesterol and fatty acids in vivo [32]. In
analogy, cafestol might affect the expression of SR-
BI, thereby influencing levels of HDL cholesterol in
the circulation.
If CETP is involved in the mechanism of action of
coffee diterpenes then it might increase the choles-
teryl ester content of VLDL and/or LDL [33]. The
effect of coffee diterpenes on the composition of the
various lipoproteins is not known. Two earlier
studies showed a significant increase in apolipopro-
tein B100 levels of 0.09 [34] and 0.13 g L21 [35]
after consumption of boiled coffee. This suggests that
the increase in LDL cholesterol is at least partly
explained by changes in the number of LDL
particles. An additional change in lipoprotein
composition cannot, however, be excluded. Since
the rise in CETP activity preceded the rise in LDL
cholesterol upon consumption of French-press cof-
fee, CETP might contribute to the LDL cholesterol-
raising effect of coffee diterpenes.
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